Top Midday Decliners

MT Newswires Live

1 hour ago

Longeveron's (LGVN) phase 2b trial of stem cell therapy laromestrocel in 40 infants with hypoplastic left heart syndrome failed to meet its primary endpoint of a change in right ventricular ejection fraction at Month 12, the company said late Wednesday.

Shares slumped 58% as intraday trading volume climbed to over 1.2 million from a daily average of about 47,000.

Viant Technology (DSP) announced late Wednesday an underwritten public offering of 8.5 million Class A shares by a selling stockholder.

Shares sank 17% as intraday trading volume soared to over 1.0 million from the stock's daily average of roughly 256,000.

Fluence Energy (FLNC) cut fiscal 2026 revenue guidance, citing ongoing supply chain issues impacting its US production. Baird downgraded Fluence to underperform from neutral and adjusted its price target to $3 from $10.

Fluence shares fell 15% as intraday trading volume climbed to over 27.4 million from a daily average of about 7.6 million.

Price: 2.83, Change: -3.85, Percent Change: -57.63

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/news/2668699177"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2668699177\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2668699177?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-18 02:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2668699177","market":"sh","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> Longeveron's (LGVN) phase 2b trial of stem cell therapy laromestrocel in 40 infants with hypoplastic left heart syndrome failed to meet its primary endpoint of a change in right ventricular ejection fraction at Month 12, the company said late Wednesday.</p><p>Shares slumped 58% as intraday trading volume climbed to over 1.2 million from a daily average of about 47,000.</p><p>Viant Technology (DSP) announced late Wednesday an underwritten public offering of 8.5 million Class A shares by a selling stockholder.</p><p>Shares sank 17% as intraday trading volume soared to over 1.0 million from the stock's daily average of roughly 256,000.</p><p>Fluence Energy (FLNC) cut fiscal 2026 revenue guidance, citing ongoing supply chain issues impacting its US production. Baird downgraded Fluence to underperform from neutral and adjusted its price target to $3 from $10.</p><p>Fluence shares fell 15% as intraday trading volume climbed to over 27.4 million from a daily average of about 7.6 million.</p><p>Price: 2.83, Change: -3.85, Percent Change: -57.63</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-18 02:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Longeveron's (LGVN) phase 2b trial of stem cell therapy laromestrocel in 40 infants with hypoplastic left heart syndrome failed to meet its primary endpoint of a change in right ventricular ejection fraction at Month 12, the company said late Wednesday.</p><p>Shares slumped 58% as intraday trading volume climbed to over 1.2 million from a daily average of about 47,000.</p><p>Viant Technology (DSP) announced late Wednesday an underwritten public offering of 8.5 million Class A shares by a selling stockholder.</p><p>Shares sank 17% as intraday trading volume soared to over 1.0 million from the stock's daily average of roughly 256,000.</p><p>Fluence Energy (FLNC) cut fiscal 2026 revenue guidance, citing ongoing supply chain issues impacting its US production. Baird downgraded Fluence to underperform from neutral and adjusted its price target to $3 from $10.</p><p>Fluence shares fell 15% as intraday trading volume climbed to over 27.4 million from a daily average of about 7.6 million.</p><p>Price: 2.83, Change: -3.85, Percent Change: -57.63</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4096","symbol_name":"电气部件与设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2668699177","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2668699177","pubTimestamp":1789670197,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Longeveron's  phase 2b trial of stem cell therapy laromestrocel in 40 infants with hypoplastic left heart syndrome failed to meet its primary endpoint of a change in right ventricular ejection fraction at Month 12, the company said late Wednesday.Shares slumped 58% as intraday trading volume climbed to over 1.2 million from a daily average of about 47,000.Viant Technology  announced late Wednesday an underwritten public offering of 8.5 million Class A shares by a selling stockholder.Shares sank 17% as intraday trading volume soared to over 1.0 million from the stock's daily average of roughly 256,000.Fluence Energy  cut fiscal 2026 revenue guidance, citing ongoing supply chain issues impacting its US production. Baird downgraded Fluence to underperform from neutral and adjusted its price target to $3 from $10.Fluence shares fell 15% as intraday trading volume climbed to over 27.4 million from a daily average of about 7.6 million.Price: 2.83, Change: -3.85, Percent Change: -57.63","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4096":"电气部件与设备","LU0823414478.USD":"法巴经典能源转换基金","FLNC":"Fluence Energy, Inc.","LGVN":"Longeveron Inc","LU2249611893.SGD":"BNP PARIBAS ENERGY TRANSITION \"CRH\" (SGD) ACC","LU2506951792.HKD":"BNP PARIBAS ENERGY TRANSITION \"CRH\" (HKDHDG)       ACC","LU2294711713.HKD":"BNP PARIBAS ENERGY TRANSITION \"C\" (HKD) ACC","LU0823414551.USD":"BNP PARIBAS ENERGY TRANSITION \"C\" (USD) INC","BK4023":"应用软件","DSP":"Viant Technology Inc.","BK4588":"碎股","BK4585":"ETF&股票定投概念","LU2357125470.USD":"BNP PARIBAS ENERGY TRANSITION \"CLASSIC RH\" (USDHDG) ACC","BK4139":"生物科技"},"translate_title":"午盘跌幅最大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LGVN":1,"FLNC":1,"DSP":1},"content_text":"Longeveron's (LGVN) phase 2b trial of stem cell therapy laromestrocel in 40 infants with hypoplastic left heart syndrome failed to meet its primary endpoint of a change in right ventricular ejection fraction at Month 12, the company said late Wednesday.Shares slumped 58% as intraday trading volume climbed to over 1.2 million from a daily average of about 47,000.Viant Technology (DSP) announced late Wednesday an underwritten public offering of 8.5 million Class A shares by a selling stockholder.Shares sank 17% as intraday trading volume soared to over 1.0 million from the stock's daily average of roughly 256,000.Fluence Energy (FLNC) cut fiscal 2026 revenue guidance, citing ongoing supply chain issues impacting its US production. Baird downgraded Fluence to underperform from neutral and adjusted its price target to $3 from $10.Fluence shares fell 15% as intraday trading volume climbed to over 27.4 million from a daily average of about 7.6 million.Price: 2.83, Change: -3.85, Percent Change: -57.63","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}